We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Pricing
Resources
Store
About us
Request a Demo Go to the Platform
en
中文 de es fr tr
Loading...
Store → Pharmaceutical Products → Pharmaceuticals, Medicinal Chemical And Botanical Products → Medicaments Containing Insulin But Not Antibiotics
Report Japan - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: May 1, 2023

Japan - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?

Japan: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Japan

The Japanese medicaments containing insulin market skyrocketed to $X in 2021, increasing by 50% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). In general, consumption saw significant growth. Medicaments containing insulin consumption peaked in 2021 and is likely to continue growth in years to come.

Medicaments Containing Insulin Exports

Exports from Japan

In 2021, overseas shipments of medicaments containing insulin but not antibiotics decreased by -12.2% to X kg for the first time since 2018, thus ending a two-year rising trend. Over the period under review, exports recorded a perceptible contraction. The growth pace was the most rapid in 2014 with an increase of 1,022% against the previous year. As a result, the exports attained the peak of X kg. From 2015 to 2021, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports dropped sharply to $X in 2021. Overall, exports, however, showed a remarkable increase. The pace of growth was the most pronounced in 2013 with an increase of 166% against the previous year. The exports peaked at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Malaysia (X kg) was the main destination for medicaments containing insulin exports from Japan, accounting for a approx. 100% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to Malaysia stood at +5.1%.

In value terms, Malaysia ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics exports from Japan.

From 2012 to 2021, the average annual rate of growth in terms of value to Malaysia amounted to +16.1%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per kg in 2021, dropping by -32.9% against the previous year. In general, the export price, however, recorded a prominent expansion. The most prominent rate of growth was recorded in 2018 when the average export price increased by 770% against the previous year. As a result, the export price attained the peak level of $X per kg. From 2019 to 2021, the average export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Malaysia.

From 2012 to 2021, the rate of growth in terms of prices for Malaysia amounted to +10.5% per year.

Medicaments Containing Insulin Imports

Imports into Japan

In 2021, overseas purchases of medicaments containing insulin but not antibiotics increased by 36% to X tons, rising for the fifth year in a row after four years of decline. Overall, imports posted a significant expansion. The growth pace was the most rapid in 2020 with an increase of 365%. Imports peaked in 2021 and are expected to retain growth in the immediate term.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2021. Over the period under review, imports recorded a significant increase. The most prominent rate of growth was recorded in 2020 when imports increased by 553%. Imports peaked in 2021 and are likely to continue growth in the immediate term.

Imports by Country

In 2021, the United States (X tons) was the main supplier of medicaments containing insulin to Japan, accounting for a approx. 100% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from the United States stood at +32.5%.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Japan.

From 2012 to 2021, the average annual growth rate of value from the United States totaled +66.2%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, picking up by 37% against the previous year. In general, the import price continues to indicate a significant expansion. The growth pace was the most rapid in 2016 an increase of 43%. Over the period under review, average import prices attained the peak figure in 2021 and is likely to see gradual growth in the near future.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to +25.5% per year.

Source: IndexBox Market Intelligence Platform

Base Year Historical Period Forecast Period Units
2022 2012-2022 2023-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?
+
The countries with the highest volumes of consumption in 2021 were the United States, Denmark and Germany, with a combined 72% share of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in the world?
+
The United States remains the largest medicaments containing insulin producing country worldwide, accounting for 67% of total volume. Moreover, medicaments containing insulin production in the United States exceeded the figures recorded by the second-largest producer, Germany, fivefold. India ranked third in terms of total production with a 5% share.
What are the leading suppliers of medicaments containing insulin but not antibiotics to Japan?
+
In value terms, the United States constituted the largest supplier of medicaments containing insulin but not antibiotics to Japan.
What are the leading importers of medicaments containing insulin but not antibiotics from Japan?
+
In value terms, Malaysia remains the key foreign market for medicaments containing insulin but not antibiotics exports from Japan.
What is the average export price for medicaments containing insulin but not antibiotics in Japan?
+
The average medicaments containing insulin export price stood at $160 per kg in 2021, dropping by -32.9% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in Japan?
+
The average medicaments containing insulin import price stood at $229,227 per ton in 2021, growing by 37% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Japan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
• Japan

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in Japan
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
REPORT DESCRIPTION
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

2.1
KEY FINDINGS
2.2
MARKET TRENDS  This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business

This Chapter is Available Only for the Professional Edition PRO
4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

This Chapter is Available Only for the Professional Edition PRO
5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

This Chapter is Available Only for the Professional Edition PRO
6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2022
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2022
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
Table 1:
Key Findings In 2022
Table 2:
Market Volume, In Physical Terms, 2012–2022
Table 3:
Market Value, 2012–2022
Table 4:
Per Capita Consumption In 2012-2022
Table 5:
Imports, In Physical Terms, By Country, 2012–2022
Table 6:
Imports, In Value Terms, By Country, 2012–2022
Table 7:
Import Prices, By Country Of Origin, 2012–2022
Table 8:
Exports, In Physical Terms, By Country, 2012–2022
Table 9:
Exports, In Value Terms, By Country, 2012–2022
Table 10:
Export Prices, By Country Of Destination, 2012–2022
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2022
Figure 2:
Market Value, 2012–2022
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2022
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2022
Figure 5:
Trade Balance, In Physical Terms, 2012-2022
Figure 6:
Trade Balance, In Value Terms, 2012-2022
Figure 7:
Per Capita Consumption, 2012-2022
Figure 8:
Market Volume Forecast to 2030
Figure 9:
Market Value Forecast to 2030
Figure 10:
Products: Market Size And Growth, By Type
Figure 11:
Products: Average Per Capita Consumption, By Type
Figure 12:
Products: Exports And Growth, By Type
Figure 13:
Products: Export Prices And Growth, By Type
Figure 14:
Production Volume And Growth
Figure 15:
Exports And Growth
Figure 16:
Export Prices And Growth
Figure 17:
Market Size And Growth
Figure 18:
Per Capita Consumption
Figure 19:
Imports And Growth
Figure 20:
Import Prices
Figure 21:
Production, In Physical Terms, 2012–2022
Figure 22:
Production, In Value Terms, 2012–2022
Figure 23:
Imports, In Physical Terms, 2012–2022
Figure 24:
Imports, In Value Terms, 2012–2022
Figure 25:
Imports, In Physical Terms, By Country, 2022
Figure 26:
Imports, In Physical Terms, By Country, 2012–2022
Figure 27:
Imports, In Value Terms, By Country, 2012–2022
Figure 28:
Import Prices, By Country Of Origin, 2012–2022
Figure 29:
Exports, In Physical Terms, 2012–2022
Figure 30:
Exports, In Value Terms, 2012–2022
Figure 31:
Exports, In Physical Terms, By Country, 2022
Figure 32:
Exports, In Physical Terms, By Country, 2012–2022
Figure 33:
Exports, In Value Terms, By Country, 2012–2022
Figure 34:
Export Prices, By Country Of Destination, 2012–2022
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces
Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices
Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET

• • •
© 2023 IndexBox, Inc